Nicholas Investment Partners, LP Reata Pharmaceuticals Inc Transaction History

Nicholas Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$126.3 - $176.56 $2.45 Million - $3.42 Million	-19,388 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$124.16 - $247.74 $2.2 Million - $4.39 Million	-17,723 Reduced 47.76%	19,388 $2.8 Million
Q4 2019 Feb 13, 2020	SELL	$74.57 - $217.92 $1.33 Million - $3.9 Million	-17,880 Reduced 32.51%	37,111 $7.59 Million
Q3 2019 Nov 13, 2019	BUY	$71.26 - $95.75 $953,601 - $1.28 Million	13,382 Added 32.16%	54,991 $4.42 Million
Q2 2019 Aug 09, 2019	BUY	$77.72 - $94.35 $1.27 Million - $1.54 Million	16,278 Added 64.26%	41,609 $3.93 Million
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $1.31 Million - $2.58 Million	25,331 New	25,331 $2.17 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.